Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001).

The human immunodeficiency virus (HIV) global epidemic has necessitated the routine enumeration of T-lymphocyte subsets, which has created a need for external quality assurance (EQA). The United Kingdom National External Quality Assessment Scheme (UK NEQAS) for Immune Monitoring provides EQA for 296 laboratories in 40 countries. In 1993, UK NEQAS developed and incorporated into its program stabilized whole blood that enables the accurate monitoring of laboratory performance. Overall, the mean interlaboratory coefficient of variation (CV) for percentage CD4(+) T-lymphocyte subset enumeration has fallen from 15% to less than 5%, as a direct result of the increased use of CD45/ side scatter (SSC) gating. Laboratories using alternative gating strategies (i.e., CD45/CD14 or forward scatter [FSC]/SSC) were about 7.4 times more likely to fail an EQA exercise. Furthermore, the adoption of single-platform technology resulted in a reduction of the overall mean interlaboratory CV for absolute CD4(+) T lymphocytes from 56% (prior to the widespread use of single-platform technology) to 9.7%. Individual laboratory deficiencies were also identified using a performance monitoring system and, through re-education by collaboration with the coordinating center, satisfactorily resolved. In conclusion, during the last 9 years, the UK NEQAS for Immune Monitoring program has highlighted the significant technological advances made by laboratories worldwide that undertake lymphocyte subset enumeration.

[1]  Ann Marie Swart,et al.  Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection , 1994, The Lancet.

[2]  F. Lacroix,et al.  Impact of unified procedures as implemented in the Canadian Quality Assurance Program for T lymphocyte subset enumeration. Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies. , 1998, Cytometry.

[3]  J. Gratama,et al.  Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. , 2002, Cytometry.

[4]  C. Sabin,et al.  Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection , 1994, BMJ.

[5]  R. Ogden,et al.  Comparative CD4 T-Cell Responses of Reverse Transcriptase Inhibitor Therapy With or Without Nelfinavir Matched for Viral Exposure , 2001, HIV Clinical Trials.

[6]  B. Bain,et al.  Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. CD4+ T lymphocyte Working Party. Members of the General Haematology Task Force of BCSH. , 1997, Clinical and laboratory haematology.

[7]  J. Fahey,et al.  Results of the flow cytometry ACTG quality control program: analysis and findings. , 1989, Clinical immunology and immunopathology.

[8]  I. Storie,et al.  Absolute CD4+ T‐lymphocyte and CD34+ stem cell counts by single‐platform flow cytometry: the way forward , 1999, British journal of haematology.

[9]  D. Fleming,et al.  Improved AIDS surveillance through laboratory-initiated CD4 cell count reporting. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[10]  T. Merigan,et al.  Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). , 2001, AIDS research and human retroviruses.

[11]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[12]  A. Phillips,et al.  Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. , 1989, AIDS.

[13]  P. Selwyn,et al.  Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[14]  D. V. van Bockstaele,et al.  Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study. , 1997, Cytometry.

[15]  M. Healy.  Outliers in clinical chemistry quality-control schemes. , 1979, Clinical chemistry.

[16]  D Barnett,et al.  Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS immune monitoring scheme. , 1996, Cytometry.

[17]  D. Recktenwald,et al.  A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. Comparison with conventional two-color immunophenotyping method. , 1992, Journal of immunological methods.

[18]  F. Ognibene,et al.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. , 1989, Annals of internal medicine.

[19]  S. Livingstone,et al.  CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990–1998 , 2000, AIDS.

[20]  M R Loken,et al.  Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. , 1990, Cytometry.

[21]  M. O'gorman,et al.  Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive Adults , 2000, Clinical Diagnostic Laboratory Immunology.

[22]  A. Landay,et al.  Assessment of Interlaboratory Variability of Immunophenotyping , 1993, Annals of the New York Academy of Sciences.

[23]  K. Reimann,et al.  Multisite Comparison of CD4 and CD8 T-Lymphocyte Counting by Single- versus Multiple-Platform Methodologies: Evaluation of Beckman Coulter Flow-Count Fluorospheres and the tetraONE System , 2000, Clinical Diagnostic Laboratory Immunology.

[24]  J K Nicholson,et al.  Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. , 1996, Cytometry.

[25]  S. Papa,et al.  Reduction of intra‐ and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training , 2000, British journal of haematology.